Ashkan Mortezavi

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

Journal: European urology

Published: May 07, 2026

Prostate Cancer Incidence, Mortality, and Survival in Switzerland.

Prostate Cancer Incidence, Mortality, and Survival in Switzerland.

Journal: JAMA network open

Published: April 21, 2026

Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.

Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.

Journal: European urology focus

Published: April 02, 2026

Prostate cancer: Value of the PI-FAB score and volume-adjusted PSA density in recurrence assessment after HIFU.

Prostate cancer: Value of the PI-FAB score and volume-adjusted PSA density in recurrence assessment after HIFU.

Journal: European journal of radiology open

Published: February 27, 2026

Letter to the Editor: Advanced and Metastatic Prostate Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up.

Letter to the Editor: Advanced and Metastatic Prostate Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up.

Journal: European urology

Published: February 20, 2026

Validation of Stockholm3 for prostate cancer detection in a swiss non-referral cohort: balancing biopsy reduction and diagnostic performance.

Validation of Stockholm3 for prostate cancer detection in a swiss non-referral cohort: balancing biopsy reduction and diagnostic performance.

Journal: World journal of urology

Published: February 06, 2026

Protocol for generating and characterizing Matrigel-free prostate cancer patient-derived organoids.

Protocol for generating and characterizing Matrigel-free prostate cancer patient-derived organoids.

Journal: STAR protocols

Published: December 22, 2025

High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?

High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 21, 2025

Re: Sasanlimab plus BCG in BCG-naive, High-risk Non-muscle Invasive Bladder Cancer: The Randomized Phase 3 CREST Trial.

Re: Sasanlimab plus BCG in BCG-naive, High-risk Non-muscle Invasive Bladder Cancer: The Randomized Phase 3 CREST Trial.

Journal: European urology

Published: September 18, 2025

Comprehensive 90-Day Morbidity Assessment Following Robot-Assisted Radical Cystectomy With Intracorporeal Diversion.

Comprehensive 90-Day Morbidity Assessment Following Robot-Assisted Radical Cystectomy With Intracorporeal Diversion.

Journal: Advances in urology

Published: June 28, 2025

Anxiety and Health-related Quality of Life in Men with Prostate Cancer Undergoing Focal Therapy: A Prospective Single-arm Phase 2 Trial.

Anxiety and Health-related Quality of Life in Men with Prostate Cancer Undergoing Focal Therapy: A Prospective Single-arm Phase 2 Trial.

Journal: European urology focus

Published: April 28, 2025

Long-term follow-up after initial negative prostate biopsy-comparison of conventional transrectal ultrasound biopsy and mpMRI/transrectal ultrasound fusion guided biopsy.

Long-term follow-up after initial negative prostate biopsy-comparison of conventional transrectal ultrasound biopsy and mpMRI/transrectal ultrasound fusion guided biopsy.

Journal: Translational andrology and urology

Published: April 12, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026